Steven M. Foord
Heptares Therapeutics (United Kingdom)(GB)
Publications by Year
Research Areas
Receptor Mechanisms and Signaling, Neuropeptides and Animal Physiology, Thyroid Disorders and Treatments, Growth Hormone and Insulin-like Growth Factors, Pancreatic function and diabetes
Most-Cited Works
- → RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor(1998)2,139 cited
- → Heterodimerization is required for the formation of a functional GABAB receptor(1998)1,172 cited
- → International Union of Pharmacology. XLVI. G Protein-Coupled Receptor List(2005)608 cited
- → Molecular Identification of High and Low Affinity Receptors for Nicotinic Acid(2003)538 cited
- → Multiple Amylin Receptors Arise from Receptor Activity-Modifying Protein Interaction with the Calcitonin Receptor Gene Product(1999)479 cited
- → International Union of Pharmacology. LVI. Ghrelin Receptor Nomenclature, Distribution, and Function(2005)236 cited
- → IUPHAR-DB: the IUPHAR database of G protein-coupled receptors and ion channels(2008)219 cited
- → Amylin Receptor Phenotypes Derived from Human Calcitonin Receptor/RAMP Coexpression Exhibit Pharmacological Differences Dependent on Receptor Isoform and Host Cell Environment(2000)169 cited
- → The Amino Terminus of Receptor Activity Modifying Proteins Is a Critical Determinant of Glycosylation State and Ligand Binding of Calcitonin Receptor-Like Receptor(1999)166 cited
- → Agonist-promoted Internalization of a Ternary Complex between Calcitonin Receptor-like Receptor, Receptor Activity-modifying Protein 1 (RAMP1), and β-Arrestin(2001)137 cited